STOCK TITAN

International Financials

INPAP
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows International (INPAP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI INPAP FY2025

Scale expansion lifted sales, but cash generation per dollar of assets weakened as the company carried a much heavier capital base.

Revenue jumped to $23.6B from $15.8B in the latest year. But operating cash flow stayed near $1.7B while free cash flow slipped to -$159M, so the larger asset base is demanding more reinvestment than it is yet returning in cash.

Because gross margin was still 29.6% while net margin fell to -14.9%, the squeeze is happening below gross profit rather than in basic production economics. That points to heavier overhead, depreciation, financing costs, or other charges absorbing value after the product is sold.

Long-term debt rose to $8.8B while cash stayed near $1.1B, which changed the balance sheet more than the cash engine. With the current ratio down to 1.3x, liquidity remains positive but the business has less internal cushioning as it funds dividends and reinvestment.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating International's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Neutral
4/9

International passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed
-0.48x

For every $1 of reported earnings, International generates $-0.48 in operating cash flow ($1.7B OCF vs -$3.5B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$23.6B
YoY+49.3%
5Y CAGR+6.1%
10Y CAGR+1.3%

International generated $23.6B in revenue in fiscal year 2025. This represents an increase of 49.3% from the prior year.

EBITDA
N/A
Net Income
-$3.5B
YoY-731.2%

International reported -$3.5B in net income in fiscal year 2025. This represents a decrease of 731.2% from the prior year.

EPS (Diluted)
$-6.95
YoY-542.7%

International earned $-6.95 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 542.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$159.0M
YoY-121.0%

International generated -$159.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 121.0% from the prior year.

Cash & Debt
$1.1B
YoY+7.8%
5Y CAGR+14.0%
10Y CAGR+0.9%

International held $1.1B in cash against $8.8B in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.85
YoY+0.0%
5Y CAGR-2.0%
10Y CAGR+1.2%

International paid $1.85 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding
627M
YoY+19.2%
5Y CAGR+9.8%
10Y CAGR+3.4%

International had 627M shares outstanding in fiscal year 2025. This represents an increase of 19.2% from the prior year.

Margins & Returns

Gross Margin
29.6%
YoY+1.6pp
5Y CAGR-0.1pp
10Y CAGR-3.8pp

International's gross margin was 29.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.6 percentage points from the prior year.

Operating Margin
N/A
Net Margin
-14.9%
YoY-18.4pp
5Y CAGR-17.6pp
10Y CAGR-19.4pp

International's net profit margin was -14.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 18.4 percentage points from the prior year.

Return on Equity
-23.7%
YoY-30.5pp
5Y CAGR-29.8pp
10Y CAGR-47.9pp

International's ROE was -23.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 30.5 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$65.0M
YoY+182.6%
5Y CAGR+9.1%
10Y CAGR-20.0%

International spent $65.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 182.6% from the prior year.

Capital Expenditures
$1.9B
YoY+101.6%
5Y CAGR+22.9%
10Y CAGR+3.6%

International invested $1.9B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 101.6% from the prior year.

INPAP Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $6.0B-0.6% $6.0B-3.5% $6.2B+1.3% $6.1B+16.7% $5.3B+34.2% $3.9B-1.4% $4.0B-1.0% $4.0B
Cost of Revenue $4.2B N/A $4.3B-12.1% $4.9B+28.1% $3.8B N/A $2.9B-14.3% $3.4B
Gross Profit $1.7B N/A $1.9B+52.8% $1.3B-13.2% $1.5B N/A $1.1B+66.8% $659.0M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $510.0M N/A $493.0M-14.7% $578.0M+18.7% $487.0M N/A $473.0M+4.4% $453.0M
Operating Income N/A N/A N/A N/A N/A N/A $237.0M-26.4% $322.0M
Interest Expense $132.0M N/A $135.0M-5.6% $143.0M+5.9% $135.0M N/A $107.0M0.0% $107.0M
Income Tax $17.0M N/A -$250.0M-725.0% $40.0M+225.0% -$32.0M N/A -$107.0M+63.5% -$293.0M
Net Income $60.0M+102.5% -$2.4B-116.3% -$1.1B-1569.3% $75.0M+171.4% -$105.0M+28.6% -$147.0M-198.0% $150.0M-69.9% $498.0M
EPS (Diluted) $0.11+102.4% $-4.52-116.3% $-2.09-1592.9% $0.14+158.3% $-0.24+42.9% $-0.42-200.0% $0.42-70.2% $1.41

INPAP Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $36.4B-4.0% $38.0B-6.4% $40.6B-4.3% $42.4B+2.9% $41.2B+80.6% $22.8B-1.6% $23.2B+0.4% $23.1B
Current Assets $8.6B-15.1% $10.1B-3.4% $10.5B+10.2% $9.5B+2.3% $9.3B+44.6% $6.4B-3.3% $6.6B+1.3% $6.6B
Cash & Equivalents $1.2B+7.9% $1.1B+15.1% $995.0M-12.3% $1.1B-1.8% $1.2B+8.9% $1.1B-8.4% $1.2B+10.5% $1.0B
Inventory $1.9B-5.5% $2.0B-7.7% $2.2B-18.0% $2.7B+2.6% $2.6B+74.3% $1.5B-17.2% $1.8B+3.9% $1.7B
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $5.3B-0.5% $5.3B-30.6% $7.7B+1.9% $7.5B+4.0% $7.2B+138.4% $3.0B0.0% $3.0B-0.1% $3.0B
Total Liabilities $21.6B-6.5% $23.1B-0.5% $23.3B-2.1% $23.8B+3.0% $23.1B+57.8% $14.6B+0.7% $14.5B+0.4% $14.5B
Current Liabilities $7.1B-10.5% $7.9B-0.9% $8.0B+11.9% $7.1B+1.9% $7.0B+64.1% $4.3B-2.2% $4.4B+5.8% $4.1B
Long-Term Debt $8.2B-7.5% $8.8B-1.7% $9.0B-7.3% $9.7B+5.7% $9.2B+71.1% $5.4B+1.0% $5.3B-0.4% $5.3B
Total Equity $14.8B-0.1% $14.8B-14.4% $17.3B-7.0% $18.6B+2.9% $18.1B+121.4% $8.2B-5.3% $8.6B+0.4% $8.6B
Retained Earnings $4.7B-3.8% $4.9B-35.0% $7.5B-15.2% $8.9B-1.9% $9.0B-3.8% $9.4B-3.2% $9.7B-0.1% $9.7B

INPAP Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $611.0M-32.5% $905.0M+49.6% $605.0M+27.1% $476.0M+265.3% -$288.0M-172.5% $397.0M-23.8% $521.0M+42.7% $365.0M
Capital Expenditures $517.0M-20.5% $650.0M+42.9% $455.0M+7.8% $422.0M+27.9% $330.0M+26.9% $260.0M+22.6% $212.0M+7.1% $198.0M
Free Cash Flow $94.0M-63.1% $255.0M+70.0% $150.0M+177.8% $54.0M+108.7% -$618.0M-551.1% $137.0M-55.7% $309.0M+85.0% $167.0M
Investing Cash Flow $565.0M+203.5% -$546.0M-24.1% -$440.0M-60.0% -$275.0M-216.0% $237.0M+236.2% -$174.0M+7.4% -$188.0M+5.5% -$199.0M
Financing Cash Flow -$1.0B-566.0% -$153.0M+49.3% -$302.0M-10.2% -$274.0M-1404.8% $21.0M+111.2% -$187.0M+16.1% -$223.0M-28.2% -$174.0M
Dividends Paid $245.0M+0.4% $244.0M-0.8% $246.0M-0.8% $248.0M+1.6% $244.0M+51.6% $161.0M-1.8% $164.0M-0.6% $165.0M
Share Buybacks $30.0M+2900.0% $1.0M0.0% $1.0M0.0% $1.0M-98.4% $62.0M+6100.0% $1.0M $0 $0

INPAP Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 28.9% N/A 31.1%+10.5pp 20.6%-7.1pp 27.7% N/A 27.6%+11.2pp 16.4%
Operating Margin N/A N/A N/A N/A N/A N/A 6.0%-2.1pp 8.0%
Net Margin 1.0%+40.7pp -39.7%-22.0pp -17.7%-18.9pp 1.2%+3.2pp -2.0%+1.8pp -3.8%-7.5pp 3.8%-8.6pp 12.4%
Return on Equity 0.4%+16.5pp -16.1%-9.7pp -6.4%-6.8pp 0.4%+1.0pp -0.6%+1.2pp -1.8%-3.5pp 1.7%-4.0pp 5.8%
Return on Assets 0.2%+6.4pp -6.3%-3.6pp -2.7%-2.9pp 0.2%+0.4pp -0.3%+0.4pp -0.6%-1.3pp 0.7%-1.5pp 2.2%
Current Ratio 1.21-0.1 1.28-0.0 1.31-0.0 1.330.0 1.33-0.2 1.51-0.0 1.53-0.1 1.59
Debt-to-Equity 0.55-0.0 0.60+0.1 0.520.0 0.52+0.0 0.51-0.1 0.66+0.0 0.610.0 0.62
FCF Margin 1.6%-2.7pp 4.3%+1.8pp 2.4%+1.5pp 0.9%+12.6pp -11.7%-15.2pp 3.5%-4.3pp 7.8%+3.6pp 4.2%

Frequently Asked Questions

International (INPAP) reported $23.6B in total revenue for fiscal year 2025. This represents a 49.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

International (INPAP) revenue grew by 49.3% year-over-year, from $15.8B to $23.6B in fiscal year 2025.

No, International (INPAP) reported a net income of -$3.5B in fiscal year 2025, with a net profit margin of -14.9%.

International (INPAP) reported diluted earnings per share of $-6.95 for fiscal year 2025. This represents a -542.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, International (INPAP) had $1.1B in cash and equivalents against $8.8B in long-term debt.

International (INPAP) had a gross margin of 29.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

International (INPAP) had a net profit margin of -14.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, International (INPAP) paid $1.85 per share in dividends during fiscal year 2025.

International (INPAP) has a return on equity of -23.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

International (INPAP) generated -$159.0M in free cash flow during fiscal year 2025. This represents a -121.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

International (INPAP) generated $1.7B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

International (INPAP) had $38.0B in total assets as of fiscal year 2025, including both current and long-term assets.

International (INPAP) invested $1.9B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, International (INPAP) spent $65.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

International (INPAP) had 627M shares outstanding as of fiscal year 2025.

International (INPAP) had a current ratio of 1.28 as of fiscal year 2025, which is considered adequate.

International (INPAP) had a debt-to-equity ratio of 0.60 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

International (INPAP) had a return on assets of -9.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

International (INPAP) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

International (INPAP) has an earnings quality ratio of -0.48x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top